Biomarkers for Alzheimer’s disease across diverse biological domains: an umbrella review and evidence map
Open Access
- 17 July 2025
- journal article
- review article
- Published by Elsevier in Journal of Advanced Research
- Vol. 82, 917-936
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging (R01AG076704)
- Institute for Information and Communications Technology Promotion
- National Institutes of Health
- Ministry of Science and ICT, South Korea (IITP-2024-RS-2024\u201300438239)
- Ministry of Science and ICT, South Korea (RS-2024-00509257)
This publication has 108 references indexed in Scilit:
- Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease PathologyJAMA Neurology, 2024
- Ocular Biomarkers for Alzheimer Disease DementiaJAMA Ophthalmology, 2023
- Association Between Retinal Layer Thickness and Cognitive Decline in Older AdultsJAMA Ophthalmology, 2022
- The Science of Prognosis in PsychiatryJAMA Psychiatry, 2018
- Association of Retinal Neurodegeneration on Optical Coherence Tomography With DementiaJAMA Neurology, 2018
- Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer DiseaseJAMA Neurology, 2015
- Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42JAMA Neurology, 2014
- Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer DiseaseArchives of Neurology, 2007
- Progression of Corpus Callosum Atrophy in Alzheimer DiseaseArchives of Neurology, 2002
- Corpus Callosum Atrophy Is a Possible Indicator of Region– and Cell Type–Specific Neuronal Degeneration in Alzheimer DiseaseArchives of Neurology, 1998